東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Therapeutic proteins against human d...

Zahid Balouch, Fahmida Khatoon.

FindBook

Google Book

Amazon

博客來

Therapeutic proteins against human diseases

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Therapeutic proteins against human diseases/ edited by Fahmida Khatoon Zahid Balouch.
其他作者:	Zahid Balouch, Fahmida Khatoon.
出版者:	Singapore :Springer Nature Singapore : : 2022.,
面頁冊數:	ix, 173 p. :ill., digital ;24 cm.
內容註:	Proteins drug targeting and its therapeutics -- Interferons -- Epidermal growth factor (egf) in wound repair -- Therapeutic protein against autoimmune disorders: Intracellular and extracellular properties -- Prions as Therapeutic proteins and their Prospect as Drug Delivery Agent -- INTERLEUKIN - 2 -- Bioinformatics resources, tools, and strategies in designing therapeutic proteins -- Therapeutic proteins used in human pancreatic disease -- Therapeutic role of soybean-derived lunasin peptide in colon cancer treatment: A recent updates from literature -- Therapeutic peptides in skin and hair disorders.
Contained By:	Springer Nature eBook
標題:	Protein drugs. -
電子資源:	https://doi.org/10.1007/978-981-16-7897-4
ISBN:	9789811678974

Therapeutic proteins against human diseases
Therapeutic proteins against human diseases[electronic resource] /edited by Fahmida Khatoon Zahid Balouch. - Singapore :Springer Nature Singapore :2022. - ix, 173 p. :ill., digital ;24 cm.

Proteins drug targeting and its therapeutics -- Interferons -- Epidermal growth factor (egf) in wound repair -- Therapeutic protein against autoimmune disorders: Intracellular and extracellular properties -- Prions as Therapeutic proteins and their Prospect as Drug Delivery Agent -- INTERLEUKIN - 2 -- Bioinformatics resources, tools, and strategies in designing therapeutic proteins -- Therapeutic proteins used in human pancreatic disease -- Therapeutic role of soybean-derived lunasin peptide in colon cancer treatment: A recent updates from literature -- Therapeutic peptides in skin and hair disorders.

This book compiles updated research about the implications of therapeutic proteins in various human diseases. The initial chapters of the book provide basic information on the therapeutic proteins and discuss techniques for their formulation, production, and analytic approaches for their characterization. The subsequent chapters shed light on therapies based on therapeutic proteins against metabolic disorders, neurological disorders, cancer, autoimmune disorders, and infectious diseases. Importantly, it presents the factors influencing the immunogenicity of therapeutic proteins, including, genetic factors, disease type, and origin of therapeutic protein, dose frequency, administration route, and treatment duration. The book also reviews the strategies for reducing immunogenicity associated with therapeutic proteins, including PEGylation, site specific mutagenesis, exon shuffling, and humanizing of monoclonal antibodies. Further, it presents strategies for improving the typical drawback associated with protein therapeutics including instability and limited penetration through biological barriers. This book covers various computational methods that are commonly used for designing therapeutic proteins and in silico method for predicting and improving in vivo efficacy of the therapeutic molecules. Lastly, the book highlights the recent advances in developing nanosized delivery systems to improve safety and efficacy of protein therapeutics. This book caters to students and researchers of medicinal chemistry, pharmaceutical sciences and therapeutics. It is also useful to clinicians working with therapeutic proteins.

ISBN: 9789811678974

Standard No.: 10.1007/978-981-16-7897-4doiSubjects--Topical Terms:

869628
Protein drugs.

LC Class. No.: RM666.P87 / T44 2022

Dewey Class. No.: 615.3

Therapeutic proteins against human diseases
LDR:03281nmm a2200349 a 4500 001 2304340
003 DE-He213
005 20220928113644.0
006 m d
007 cr nn 008maaau
008 230409s2022 si s 0 eng d
020 $a 9789811678974 $q (electronic bk.)
020 $a 9789811678967 $q (paper)
024 7 $a 10.1007/978-981-16-7897-4 $2 doi
035 $a 978-981-16-7897-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RM666.P87 $b T44 2022
072 7 $a MMZ $2 bicssc
072 7 $a MJC $2 bicssc
072 7 $a PSY028000 $2 bisacsh
072 7 $a MKZ $2 thema
072 7 $a MJC $2 thema
082 0 4 $a 615.3 $2 23
090 $a RM666.P87 $b T398 2022
245 0 0 $a Therapeutic proteins against human diseases $h [electronic resource] / $c edited by Fahmida Khatoon Zahid Balouch.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a ix, 173 p. : $b ill., digital ; $c 24 cm.
505 0 $a Proteins drug targeting and its therapeutics -- Interferons -- Epidermal growth factor (egf) in wound repair -- Therapeutic protein against autoimmune disorders: Intracellular and extracellular properties -- Prions as Therapeutic proteins and their Prospect as Drug Delivery Agent -- INTERLEUKIN - 2 -- Bioinformatics resources, tools, and strategies in designing therapeutic proteins -- Therapeutic proteins used in human pancreatic disease -- Therapeutic role of soybean-derived lunasin peptide in colon cancer treatment: A recent updates from literature -- Therapeutic peptides in skin and hair disorders.
520 $a This book compiles updated research about the implications of therapeutic proteins in various human diseases. The initial chapters of the book provide basic information on the therapeutic proteins and discuss techniques for their formulation, production, and analytic approaches for their characterization. The subsequent chapters shed light on therapies based on therapeutic proteins against metabolic disorders, neurological disorders, cancer, autoimmune disorders, and infectious diseases. Importantly, it presents the factors influencing the immunogenicity of therapeutic proteins, including, genetic factors, disease type, and origin of therapeutic protein, dose frequency, administration route, and treatment duration. The book also reviews the strategies for reducing immunogenicity associated with therapeutic proteins, including PEGylation, site specific mutagenesis, exon shuffling, and humanizing of monoclonal antibodies. Further, it presents strategies for improving the typical drawback associated with protein therapeutics including instability and limited penetration through biological barriers. This book covers various computational methods that are commonly used for designing therapeutic proteins and in silico method for predicting and improving in vivo efficacy of the therapeutic molecules. Lastly, the book highlights the recent advances in developing nanosized delivery systems to improve safety and efficacy of protein therapeutics. This book caters to students and researchers of medicinal chemistry, pharmaceutical sciences and therapeutics. It is also useful to clinicians working with therapeutic proteins.
650 0 $a Protein drugs. $3 869628
650 0 $a Proteins $x Therapeutic use. $3 1005397
650 1 4 $a Therapeutics. $3 680391
650 2 4 $a Diseases. $3 618693
650 2 4 $a Pharmacology. $3 634543
650 2 4 $a Medical Biochemistry. $3 892387
650 2 4 $a Protein Biochemistry. $3 3603770
700 1 $a Zahid Balouch, Fahmida Khatoon. $3 3606485
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-16-7897-4
950 $a Medicine (SpringerNature-11650)